Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Understanding the timing of transmission dynamics of Covid-19 is crucial for optimising public health interventions and reducing the burden on communities.

Man wearing a face mask on public transport

Knowledge of the period of high infectiousness is particularly useful in the context of contact tracing as it allows to identify the contacts at highest risk of having contracted the disease, maximising the number of infectious individuals in quarantine while minimising the number of people unnecessarily isolated. The preprint paper 'The timing of Covid-19 transmission', published in MedRxiv, is centered around the question “When is someone who has been infected with COVID-19 most likely to infect others?”.

The analysis focuses on individuals who eventually develop symptoms, studying 191 transmission pairs from multiple data sets. Each transmission pair includes an index case and a secondary case, infected by the index case. Datasets were selected because they contained information not only about the dates of onset of symptoms for both cases, but also intervals of exposure for the index and/or secondary case. For these pairs and individuals, four key timings related to Covid-19 transmission were known or inferred.

Read more about the key findings in a blog on the Coronavirus Fraser Group website. There is also in a media update on the Big Data Institute website

Similar stories

Oxford vaccine reaches one billion doses released

The University of Oxford’s and our partners AstraZeneca have today announced that one billion doses of the ChAdOx1 nCov-19 coronavirus vaccine have been released, to more than 170 countries, marking a key milestone as part of the University and AstraZeneca’s joint vision to make the available to the world, on a not-for-profit basis for the world during the pandemic, and in perpetuity for low- and middle-income countries.

Research programme tackling COVID-19 variants of concern receives funding boost

A gift from the Red Avenue Foundation will enable the expansion of a major research programme aimed at rapidly identifying and interrogating emerging COVID-19 variants.

Phase I trial begins of new vaccine against the Plague

Researchers at the University of Oxford today launched a Phase 1 trial to test a new vaccine against plague.

New therapeutic targets identified in the treatment of psoriatic arthritis

Researchers identify two inflammatory-driving proteins, osteopontin and CCL2, highly expressed in psoriatic arthritis joints.

Treatment choice for rotator cuff disorders could create efficiency and savings for the NHS

A trial that evaluated the clinical and cost effectiveness of physiotherapy treatments for rotator cuff disorders suggests cost savings can be made while maintaining positive patient outcomes.